|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2010-7-23
|
|
pubmed:abstractText |
Interleukin-16 (IL-16) plays a fundamental role in inflammatory diseases, as well as in the development and progression of tumors. A T-to-C polymorphism at the -295 position in the promoter region of the IL-16 gene has been described. This variation might lead to altered IL-16 expression, and might modulate an individual's susceptibility to cancer. The objective of the present study was to determine if IL-16 polymorphism is associated with risk of renal cell carcinoma (RCC).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1442-2042
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
700-7
|
|
pubmed:meshHeading |
pubmed-meshheading:20529140-Adult,
pubmed-meshheading:20529140-Asian Continental Ancestry Group,
pubmed-meshheading:20529140-Carcinoma, Papillary,
pubmed-meshheading:20529140-Carcinoma, Renal Cell,
pubmed-meshheading:20529140-Case-Control Studies,
pubmed-meshheading:20529140-Female,
pubmed-meshheading:20529140-Genetic Predisposition to Disease,
pubmed-meshheading:20529140-Humans,
pubmed-meshheading:20529140-Interleukin-16,
pubmed-meshheading:20529140-Kidney Neoplasms,
pubmed-meshheading:20529140-Male,
pubmed-meshheading:20529140-Middle Aged,
pubmed-meshheading:20529140-Polymorphism, Single Nucleotide,
pubmed-meshheading:20529140-Risk Factors
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
IL-16 polymorphism and risk of renal cell carcinoma: association in a Chinese population.
|
|
pubmed:affiliation |
Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
